New breast cancer drug approved by the FDA

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

(KTVI) - There is a new medicine to treat breast cancer before surgery.  It's the first drug of its kind approved for use.

Dr. Theresa Schwartz is a breast surgeon with Saint Louis University Hospital and she talks about  "Perjeta."

It was just approved by the FDA. It benefits women with a form of early-stage breast cancer who face a high risk of having their cancer spread to other parts of the body.

The FDA granted the drug accelerated approval for its new use based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations.

To learn more, visit Perjeta.comSLU's Cancer Center